Deletion of 11q23 is a frequent event in the evolution ofMYCN single-copy high-risk neuroblastomas
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
1999 • 1,843 citations
Molecular Biology of Neuroblastoma
1999 • 644 citations
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
1999 • 250 citations
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
1997 • 185 citations
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000 • 161 citations
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
1998 • 138 citations
Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
1997 • 93 citations
Comparative genomic hybridization study of primary neuroblastoma tumors
1997 • 73 citations
Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis
1997 • 34 citations
Cited By (0)
No citing papers found in database